-
-
Available Formats
- Options
- Availability
- Priced From ( in USD )
-
Available Formats
-
- Immediate download
- $223.00
- Add to Cart
-
- Printed Edition
- Ships in 1-2 business days
- $223.00
- Add to Cart
-
- Printed Edition + PDF
- Immediate download
- $347.00
- Add to Cart
Customers Who Bought This Also Bought
-
ISO 15189:2022
Priced From $250.00 -
ISO 17822:2020
Priced From $223.00 -
ISO/TS 20914:2019
Priced From $250.00 -
ISO 22367:2020
Priced From $278.00
About This Item
Full Description
ISO 17822:2020 describes the particular clinical laboratory practice requirements to ensure the quality of detection, identification and quantification of microbial pathogens using nucleic acid amplification tests (NAAT).
It is intended for use by laboratories that develop, and/or implement and use, or perform NAAT for medical, research or health-related purposes. This document does not apply to the development of in vitro diagnostic (IVD) medical devices by manufacturers. However, it does include verification and validation of such devices and/or the corresponding processes when implemented and used by the laboratories.
Document History
-
ISO 17822:2020
viewing
In vitro diagnostic test systems - Nucleic acid amplification-based examination procedures for detection and identification of microbial pathogens - Laboratory quality practice guideLaboratory quality practice guide- Most Recent
-
ISO/TS 17822-1:2014
In vitro diagnostic test systems - Qualitative nucleic acid-based in vitro examination procedures for detection and identification of microbial pathogens - Part 1: General requirements, terms and definitions- Historical Version